FDA approves 20-week Eylea-HD dosing_during_second_year_for wet AMD and DME: https://www.globenewswire.com/news-release/2026/04/02/3267657/0/en/EYLEA-HD-aflibercept-Approved-by-FDA-as-First-and-Only-Injectable-Anti-VEGF-with-Dosing-Intervals-Up-to-5-Months-for-Wet-Age-related-Macular-Degeneration-wAMD-and-Diabetic-Macular-.html